Tumoral aspects of plasmacytoid dendritic cells: What do we know in 2009?

References

• Lennert K, Remmele W. Karyometrische Untersuchungen an Lymphknotenzellen des Menschen: I: Mitt Germinoblasten, Lymphoblasten und Lymphozyten. Acta Hematol (Basel). 1958; 19:99.
   PubMedGoogle Scholar
• Lennert K, Kaiserling E, Muller-Hermelink HK. Letter: T-associated plasma-cells. Lancet. 1975; 1:1031.
   PubMed Web of Science ®Google Scholar
• Vollenweider R, Lennert K. Plasmacytoid T-cell clusters in non-specific lymphadenitis. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983; 44:1.
   Google Scholar
• Papadimitriou CS, Stephanaki-Nikou SN, Malamou-Mitsi VD. Comparative immunostaining of T-associated plasma cells and other lymph-node cells in paraffin sections. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983; 43:31.
   Google Scholar
• Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997; 185:1101.
   PubMed Web of Science ®Google Scholar
• Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, Lund-Johansen F. Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA. 1997; 94:12551.
   PubMed Web of Science ®Google Scholar
• Strobl H, Scheinecker C, Riedl E, Csmarits B, Bello-Fernandez C, Pickl WF, Majdic O, Knapp W. Identification of CD68+ lin − peripheral blood cells with dendritic precursor characteristics. J Immunol. 1998; 161:740.
   Google Scholar
• Sorg RV, Kogler G, Wernet P. Identification of cord blood dendritic cells as an immature CD11c − population. Blood. 1999; 93:2302.
   PubMed Web of Science ®Google Scholar
• Facchetti F, De Wolf-Peeters C, De Vos R, van den Oord JJ, Pulford KA, Desmet VJ. Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum Pathol. 1989; 20:588.
   PubMed Web of Science ®Google Scholar
• Facchetti F, de Wolf-Peeters C, van den Oord JJ, de Vos R, Desmet VJ. Plasmacytoid monocytes (so-called plasmacytoid T-cells) in Kikuchi's lymphadenitis. An immunohistologic study. Am J Clin Pathol. 1989; 92:42.
   PubMed Web of Science ®Google Scholar
• Harris NL, Bhan AK. “Plasmacytoid T cells” in Castleman's disease. Immunohistologic phenotype. Am J Surg Pathol. 1987; 11:109.
   PubMed Web of Science ®Google Scholar
• Facchetti F, De Wolf-Peeters C, van den Oord JJ, Desmet VJ. Plasmacytoid monocytes (so-called plasmacytoid T cells) in Hodgkin's disease. J Pathol. 1989; 158:57.
   Google Scholar
• Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P. Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol. 2000; 165:4062.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006; 25:383.
   PubMed Web of Science ®Google Scholar
• Varughese N, Petrella T, Singer M, Carlson A. Plasmacytoid (CD123+ CD68+) monocytes may play a crucial role in the pathogenesis of Hydroa Vacciniforme. Am J Dermatopathol. 2009; 31:828–833.
   Google Scholar
• Facchetti F, de Wolf-Peeters C, van den Oord JJ, Meijer CJ, Pals ST, Desmet VJ. Anti-high endothelial venule monoclonal antibody HECA-452 recognizes plasmacytoid T cells and delineates an “extranodular” compartment in the reactive lymph node. Immunol Lett. 1989; 20:277.
   Google Scholar
• Facchetti F, Vermi W, Santoro A, Vergoni F, Chilosi M, Doglioni C. Neoplasms derived from plasmacytoid monocytes/interferon-producing cells: Variability of CD56 and granzyme B expression. Am J Surg Pathol. 2003; 27:1489.
   Google Scholar
• Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood. 2003; 101:5007.
   Google Scholar
• Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, Gunther G, Johnston I, Lanzavecchia A, Nagasaka T, Okada T, Vermi W, Winkels G, Yamamoto T, Zysk M, Yamaguchi Y, Schmitz J. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001; 194:1823.
   PubMed Web of Science ®Google Scholar
• Muller-Hermelink HK, Stein H, Steinmann G, Lennert K. Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell. Am J Surg Pathol. 1983; 7:849.
   PubMed Web of Science ®Google Scholar
• Vermi W, Facchetti F, Rosati S, Vergoni F, Rossi E, Festa S, Remotti D, Grigolato P, Massarelli G, Frizzera G. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol. 2004; 28:585.
   PubMed Web of Science ®Google Scholar
• Chen YC, Chou JM, Ketterling RP, Letendre L, Li CY. Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia. Am J Clin Pathol. 2003; 120:874.
   Google Scholar
• Harris NL, Demirjian Z. Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization. Am J Surg Pathol. 1991; 15:87.
   PubMed Web of Science ®Google Scholar
• Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005; 105:3768.
   PubMed Web of Science ®Google Scholar
• Chan JKC, Jaffe ES, Ralfkiaer E. 2001. Blastic NK-cell lymphoma. In: Tumors WHOCo, editors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press214.
   Google Scholar
• Facchetti F, Jones D, Petrella T. 2008. Blastic plasmacytoid dendritic cell neoplasm. In: Tumors WHOCo, editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon. France: IARC Press145.
   Google Scholar
• Petrella T, Dalac S, Maynadie M, Mugneret F, Thomine E, Courville P, Joly P, Lenormand B, Arnould L, Wechsler J, Bagot M, Rieux C, Bosq J, Avril MF, Bernheim A, Molina T, Devidas A, Delfau-Larue MH, Gaulard P, Lambert D. CD4+ CD56+ cutaneous neoplasms: A distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanes (GFELC). Am J Surg Pathol. 1999; 23:137.
   PubMed Web of Science ®Google Scholar
• Petrella T, Comeau MR, Maynadie M, Couillault G, De Muret A, Maliszewski CR, Dalac S, Durlach A, Galibert L. ‘Agranular CD4+ CD56+ hematodermic neoplasm’ (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002; 26:852.
   PubMed Web of Science ®Google Scholar
• Chaperot L, Bendriss N, Manches O, Gressin R, Maynadié M, Trimoreau F, Orfeuvre H, Corront B, Feuillard J, Sotto JJ, Bensa JC, Briere F, Plumas J, Jacob MC. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001; 97:3210.
   PubMed Web of Science ®Google Scholar
• Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA. Blastic NK-cell lymphomas (agranular CD4+ CD56+ hematodermic neoplasms): A review. Am J Clin Pathol. 2005; 123:662.
   PubMed Web of Science ®Google Scholar
• Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet M, Joly P, Dompmartin A, D'Incan M, Maubec E, Grange F, Dereure O, Prey S, Barete S, Wetterwald W, Fraitag F, Petrella T. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?. Br J Dermatol 2009; Jun 22 [Epub ahead of print].
   Google Scholar
• Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: A primitive systemic malignancy related to myelomonocytic leukemia. Cancer. 2002; 94:2401.
   PubMed Web of Science ®Google Scholar
• Narita M, Kuroha T, Watanabe N, Hashimoto S, Tsuchiyama J, Tochiki N, Saitoh A, Satoh N, Furukawa T, Toba K, Fuse I, Aizawa Y, Takahashi M. Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability. Acta Haematol. 2008; 120:91.
   Google Scholar
• Facchetti F, Pileri SA, Agostinelli C, Martelli MP, Paulli M, Venditti A, Martelli MF, Falini B. Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm. Haematologica. 2009; 94:285.
   Google Scholar
• Jardin F, Callanan M, Penther D, Ruminy P, Troussard X, Kerckaert JP, Figeac M, Parmentier F, Rainville V, Vaida I, Bertrand P, Duval AB, Picquenot JM, Chaperot L, Marolleau JP, Plumas J, Tilly H, Bastard C. Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+ CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease. Leukemia. 2009; 23:698–707.
   PubMed Web of Science ®Google Scholar